Grey Cloak Tech (OTC: GRCK) this morning said that Eqova Live Sciences, the company’s acquisition target, exhibited at Denver’s Integrative Medicine Summit in Denver, Colorado, on October 7, 2017. Grey Cloak signed a Letter of Intent to acquire Eqova Life Sciences on September 19, 2017. Eqova Life Sciences develops clinical grade Full Spectrum Hemp Oil … Continue reading “NetworkNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Acquisition Target Eqova Debuts New CannaBio Salve at Denver’s Integrative Medicine Summit”
Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: LPAD 32.73% – News: Enters definitive merger agreement for Icynene to acquire all outstanding shares USEG 26.92% – News: Enters agreement to reduce outstanding debt through an exchange transaction … Continue reading “NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 5, 2017”
The rise of the sharing economy model and gig economy, empowered by mobile IT and big data, has rapidly transformed an antiquated labor market, where the average independent worker often ended up dependent on temp agencies (which aggregated this labor pool) in order to find employment. However, this evolution of the labor market has come … Continue reading “ShiftPixy, Inc. (NASDAQ: PIXY) is “One to Watch””
Traditions can be good, for the most part, but when new ideas and technological advancements start to make those time-honored methods of doing things easier, faster and better, those customary actions, thoughts or beliefs are bound to change with the times. Take blockchain technology, for instance. It’s the electronic ledger used for securely recording person-to-person … Continue reading “Custom Built Blockchain Technology – It’s Not Just for Cryptocurrencies”
Shares of Cleantech Solutions International (NASDAQ: CLNT) are up 11% this morning after the company said it has entered into exclusive discussions with ECoin Development Limited regarding the development and operation of a cryptocurrency system to support the development of a sharing economy ecosystem based on blockchain solutions. Cleantech’s board of directors intends to form … Continue reading “NetworkNewsBreaks – Cleantech Solutions International, Inc. (NASDAQ: CLNT) Enters into Agreement with ECoin Development to Create a Cryptocurrency System”
ARCA biopharma (NASDAQ: ABIO) this morning said the GENETIC-AF trial Data and Safety Monitoring Board (DSMB) has completed its pre-specified phase 2B interim analysis and has recommended completion of the study with no changes to the trial design. GENETIC-AF is a clinical trial evaluating Gencaro™ as a candidate for the treatment of atrial fibrillation (AF). … Continue reading “NetworkNewsBreaks – Data and Safety Monitoring Board Recommends Completion of ARCA biopharma, Inc.’s (NASDAQ: ABIO) GENETIC-AF Trial”
Shares of xG Technology (NASDAQ: XGTI) are up 7% after the company this morning said that its Vislink business has received an impressive order from a leading medical device manufacturer of microwave communications equipment. The order, which is valued at approximately $1.5 million, includes Vislink communications equipment that will be used as part of an … Continue reading “NetworkNewsBreaks – xG Technology, Inc.’s (NASDAQ: XGTI) Vislink Receives $1.5M Microwave Communications Equipment Order”
Shares of Semnur Pharmaceuticals (NASDAQ: SRNE) are up 12.1% after the company posted positive data from is phase 1/2 pharmacokinetic bridging trial of its lead product, SP-102, for the treatment of lumbar radicular pain. The trial achieved its primary pharmacokinetic endpoint and demonstrated that a single epidural injection of SP-102 can provide a sustained analgesic … Continue reading “NetworkNewsBreaks – Semnur Pharmaceuticals, Inc.’s (NASDAQ: SRNE) SP-102 Phase 1/2 Trial Meets Primary Endpoint, Preparing for Safety and Efficacy Studies; Shares Surge”
Moving toward offering the very first therapy for treating epidermolysis bullosa (EB), InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) recently announced it has signed an agreement with Pharmaseed Ltd. (http://nnw.fm/4lZzC) to develop a final formulation for INM-750, InMed’s lead compound, which is being developed as a therapy for EB and for other potential dermatological and … Continue reading “InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Takes Additional Step toward Clinical Trials for INM-750”
Aegis Capital has issued a ‘Buy’ rating and price target of $11 on Recro Pharma (NASDAQ: REPH) following the company’s recent report of positive top-line results from its phase 3 safety study evaluating intravenous (IV) meloxicam following major surgery. The analyst noted that the final clinical requirement was met for the IV Meloxicam NDA, and … Continue reading “NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating, $11 PT on Recro Pharma, Inc. (NASDAQ: REPH)”
